SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Skeeter Bug who wrote (28984)6/26/1999 8:14:00 PM
From: Henry Niman  Respond to of 32384
 
SB, There was no way that LGND was going to promise 4Q '98 NDA filing for oral Targretin, because in Aug, they still hadn't chosen whether oral or topical would be filed first. Moreover, Mud indicated that the June, '99 filing was as much as 9 months late, which would have meant that LGND indicated a 3Q '98 filing.